Correlation Between Shanghai Rightongene and Hengkang Medical

Can any of the company-specific risk be diversified away by investing in both Shanghai Rightongene and Hengkang Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rightongene and Hengkang Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shanghai Rightongene Biotechnology and Hengkang Medical Group, you can compare the effects of market volatilities on Shanghai Rightongene and Hengkang Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rightongene with a short position of Hengkang Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rightongene and Hengkang Medical.

Diversification Opportunities for Shanghai Rightongene and Hengkang Medical

0.73

Correlation Coefficient

Shanghai Rightongene  Hengkang Medical

Poor diversification

The 3 months correlation between Shanghai and Hengkang is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rightongene Biotechno and Hengkang Medical Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hengkang Medical and Shanghai Rightongene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rightongene Biotechnology are associated (or correlated) with Hengkang Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hengkang Medical has no effect on the direction of Shanghai Rightongene i.e., Shanghai Rightongene and Hengkang Medical go up and down completely randomly.

Pair Corralation between Shanghai Rightongene and Hengkang Medical

Assuming the 90 days trading horizon Shanghai Rightongene Biotechnology is expected to under-perform the Hengkang Medical. In addition to that, Shanghai Rightongene is 1.13 times more volatile than Hengkang Medical Group. It trades about -0.05 of its total potential returns per unit of risk. Hengkang Medical Group is currently generating about -0.01 per unit of volatility. If you would invest  339.00  in Hengkang Medical Group on October 5, 2024 and sell it today you would lose (76.00) from holding Hengkang Medical Group or give up 22.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Shanghai Rightongene Biotechno  vs.  Hengkang Medical Group

Shanghai Rightongene

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Shanghai Rightongene Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Hengkang Medical

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hengkang Medical Group are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hengkang Medical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Shanghai Rightongene and Hengkang Medical

The main advantage of trading using opposite Shanghai Rightongene and Hengkang Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rightongene position performs unexpectedly, Hengkang Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hengkang Medical will offset losses from the drop in Hengkang Medical's long position.

The idea behind Shanghai Rightongene Biotechnology and Hengkang Medical Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.